Muhlenkamp & CO Inc Jazz Pharmaceuticals PLC Call Options Transaction History
Muhlenkamp & CO Inc
- $306 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding JAZZ
# of Institutions
512Shares Held
57.7MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$789 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$719 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$275 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$266 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$167 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.99B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...